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Abstract 
We have reported previously that hydrogen peroxide induces arachidonic acid release from prelabeled vascular smooth muscle cells. 
Here, we studied the effect of hydrogen peroxide on the phosphorylation f cytosolic phospholipase A 2 in these cells. Hydrogen peroxide 
induced a rapid, time-dependent i crease in the phosphorylation f cytosolic phospholipase A 2. Hydrogen peroxide also increased 
arachidonic acid release from prelabeled cells in a time-dependent manner similar to that of phosphorylation f cytosolic phospholipase 
A 2. Protein kinase C depletion significantly inhibited the hydrogen peroxide-stimulated cytosolic phospholipase A 2 phosphorylation a d 
arachidonic acid release. Hydrogen peroxide caused a time-dependent i crease in mitogen activated protein kinase activity. Taken 
together, these findings uggest that eytosolic phospholipase A 2 may, at least in part, contribute to arachidonic acid release induced by 
hydrogen peroxide and this effect appears to be mediated by protein kinase C and mitogen activated protein kinase. 
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1. Introduction 
We have demonstrated in earlier studies that hydrogen 
peroxide, a reactive oxygen :species and a cellular oxidant, 
stimulates arachidonic acid release from prelabeled vascu- 
lar smooth muscle cells (VSMC) and that the arachidonic 
acid mediates the hydrogen peroxide-induced c-los and 
c-jun mRNA expression [1,2]. We have also shown that 
the hydrogen peroxide-stimulated arachidonic acid release, 
and c-los and c-jun mRNA expression, can be blocked by 
mepacrine, a non-specific phospholipase A 2 (PLA 2) in- 
hibitor, raising the possibility of PLA 2 action in these 
events [1,2]. 
PLA2s are a group of enzymes that hydrolyze the 
sn-2-acyl ester bond of phospholipids, generating free fatty 
acids and lysophopholipids [3-5]. Several ow molecular 
mass (14-20 kDa), secretory type PLA2s (sPLA2s) have 
been purified and cloned [6,7]. Major features of sPLA2s 
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include their sensitivity to sulfhydryl reagents [6,8], their 
requirement for millimolar concentrations of calcium [6,7] 
and their lack of specificity for substrates with arachidonic 
acid in the sn-2 position [9]. Recently, however, several 
groups have identified, purified and cloned a high molecu- 
lar mass cytosolic PLA 2 (cPLA 2) [10-15]. This cPLA 2 is 
expressed in a variety of cell types including fibroblasts, 
macrophages, and mesangial cells [10-15]. Furthermore, 
this cPLA 2 is mainly cytosolic [10-15], is active at 
physiological concentrations of calcium [16,17], is specific 
for substrates with arachidonic acid at the sn-2 position 
[16] and is regulated by phosphorylation a d dephospho- 
rylation [18-23]. It has been reported that arachidonic acid 
and its oxygenated metabolites play an important role in an 
array of biological processes uch as signal transduction 
[24], chemotaxis [25], contraction [26,27] and cell growth 
and differentiation [28-34]. Given the substrate specificity 
of cPLA e and the pleiotrophic effects of arachidonic acid, 
we hypothesized that cPLA 2 may be important in cellular 
signaling and perhaps may transduce the hydrogen perox- 
ide-elicited signals in VSMC. The purpose of the present 
study was, therefore, to examine whether hydrogen perox- 
ide activates cPLA 2 in VSMC. In this communication we 
demonstrate for the first time that hydrogen peroxide 
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stimulates phosphorylation f cPLA 2 in VSMC and pro- 
tein kinase C, and mitogen activated protein kinase may 
mediate this effect. 
2. Materials and methods 
2.1. Materials 
Aprotinin, arachidonic acid, benzamidine, bovine myelin 
basic protein, calmidazolium, EDTA, EGTA, fl-glycero- 
phosphate, leupeptin, pepstatin A, phorbol 12,13-di- 
butyrate, phorbol 12-myristate 13-acetate, phosphoserine, 
phosphothreonine, phosphotyrosine, PMSF and sodium or- 
thovanadate (Na3VO 4) were obtained from Sigma (St. 
Louis, MO). 5,6,8,9,11,12,14,15 [3H]arachidonic a id (221 
Ci/mmol) and [32 P]orthophosphoric acid (8500 Ci/mmol) 
were purchased from NEN (Boston, MA). [y-32p]ATP 
(5000 Ci/mmol) was from Amersham (Arlington Heights, 
IL). ERK-1 and ERK-2 anti-rabbit antibodies were bought 
from Santa Cruz Biotechnology (Santa Cruz, CA). 
2.2. Cell culture 
VSMC were isolated from the thoracic aortae of 200- 
250 g male Sprague-Dawley rats by enzymatic dissociation 
as described elsewhere [35]. Cells were grown in Dul- 
becco's modified Eagle's medium (DMEM) supplemented 
with 10% (v/v)  heat-inactivated calf serum, 100 U/ml  
penicillin and 100 /xg/ml streptomycin. Cultures were 
maintained in humidified 95% air/5% CO 2 at 37°C by 
passage of 1-3 • 105 cells/ml on reaching confluence. For 
all experiments, cells at 70-80% confluence were made 
quiescent by incubation for 48 h in fresh DMEM contain- 
ing 0.1% calf serum. Cells were used at passage numbers 
8-18. 
2.3. [ 3H]Arachidonic acid release 
VSMC were grown for 24 h in DMEM containing 10% 
serum and 0.5 /.LCi/ml [3H]arachidonic acid [36]. Cells 
were then growth-arrested by incubation for 48 h in fresh 
DMEM containing 0.1% serum and 0.5 /zCi/ml 
[3H]arachidonic a id. To initiate the experiment, cells were 
rinsed four times with, and incubated at 37°C in, 1 ml 
DMEM with or without agent. At the indicated times, the 
medium was removed and extracted with two volumes of 
chloroform/methanol (1:1). The organic phase was evapo- 
rated under nitrogen, resuspended in 200 /zl chloroform, 
spotted on Whatman silica gel 60A LK6D TLC plates and 
developed with the organic phase of the mixture ethyl 
acetate/hexane/acetic acid/water (85:35:15:90 v/v).  1 
/zM unlabeled arachidonic acid standard was added as a 
carrier. The spot corresponding to arachidonic acid was 
visualized with iodine vapor, scraped, and its radioactivity 
measured by liquid scintillation spectrometry. 
2.4. Phosphorylation of cytosolic PLA 2 
Growth-arrested VSMC were labeled with 300/zCi/ml 
[32p]orthophosphate for 3 h at 37°C in Hepes-buffered salt 
solution (130 mM NaC1, 5 mM KCI, 1 mM MgC12, 1.5 
mM CaC12, 20 mM Hepes (pH 7.4)) before exposure to 
200 /xM hydrogen peroxide. At the end of the stimulation 
period, cells were rinsed with ice-cold phosphate-buffered 
saline (PBS) and lysed on ice for 15 min in 1.0 ml of 150 
mM NaCI, 1% SDS, 50 mM Tris-HC1 (pH 7.5), 1 mM 
sodium orthovanadate, 0.5 mM PMSF, 50 mM NaF, 2 mM 
sodium pyrophosphate, 80 mM /3-glycerophosphate nd 2 
mM EGTA. The cell lysates were then clarified by centrif- 
ugation for 30 min at 14 000 rpm in a microfuge at 4°C. 
Cell lysates containing equal amounts of TCA-precipitable 
cpm were then incubated with 10 ~1 of polyclonal cPLA 2 
antiserum overnight at 4°C. 50 /xl of protein A-Sepharose 
bead suspension in water (50% v/v)  were added to the 
samples and incubated for 90 min on ice with rocking. The 
beads were then collected by centrifugation at 6000 rpm 
for 1 min at 4°C in a microfuge, washed five times with 
ice-cold lysis buffer and once with ice-cold PBS. The 
immunoprecipitated proteins were dissolved by heating the 
beads at 100°C for 5 min in 40/zl Laemmli sample buffer 
and were separated by electrophoresis on 0.1% SDS, 10% 
polyacrylamide gels under reducing conditions [37]. The 
gels were dried and exposed to Kodak X-Omat AR X-ray 
film with an intensifying screen at -70°C for 2 days. 
2.5. Phosphoamino acid analysis 
Cells were treated as described above for measurement 
of cPLA 2 phosphorylation. Following cell lysis, immuno- 
precipitation and SDS-PAGE, proteins were transferred to 
a PVDF membrane (Immobilon, Millipore, Bedford, MA) 
by electroblotting overnight at 100 mA [38]. After transfer, 
the membrane was autoradiographed. The cPLA 2 band 
was excised and exposed to vapors of 5.7 M HCI at l l0°C 
for 4 h in a reactivial (Pierce, Rockford, IL). After acid 
hydrolysis, one drop of methanol was placed on the mem- 
brane patches and amino acids and peptide fragments were 
extracted with 1 ml of water [39]. A mixture of unlabeled 
phosphoserine, phosphothreonine and phosphotyrosine 
(100 nmol each) was added to the aqueous extract before 
lyophilization over NaOH. Samples were dissolved in 20 
/xl of water and spotted on a 20 × 20 cm cellulose thin 
layer chromatography plate (J.T. Baker, Phillipsburg, NJ). 
The phosphoamino acids were separated by one-dimen- 
sional electrophoresis in 7.8% acetic acid and 2.2% formic 
acid (pH 1.9) at 500 V for 4 h. Standards were visualized 
with ninhydrin before autoradiography. 
2.6. Western blot analysis 
Growth-arrested VSMC were incubated at 37°C for 
various times in the presence and absence of 200 /xM 
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hydrogen peroxide. After incubation, medium was aspi- 
rated, cells rinsed with cold PBS and frozen immediately 
in liquid nitrogen. Cells were then thawed in 250 ~1 of 
lysis buffer (50 mM Hepes (pH 7.4), containing 50 mM 
sodium pyrophosphate, 50 mM sodium fluoride, 50 mM 
sodium chloride, 5 mM EDTA, 5 mM EGTA, 2 mM 
sodium orthovanadate, 0.5 mM PMSF, 10 /zg/ml leu- 
peptin and 0.01% Triton X-100) and sonicated. Cell lysates 
were cleared by centrifugation at 14000 rpm for 20 min in 
a microfuge. Cell lysates containing equal amounts of 
proteins from each condition were separated by SDS-PAGE 
and transferred electrophoretically to nitrocellulose mem- 
branes. The membranes were probed with 1 /zg/ml of 
ERK-1 and ERK-2 anti-rabbit primary antibodies. After 
treating the membrane with peroxidase conjugated goat 
anti-rabbit secondary antibodies, peroxidase activity was 
detected using ECL reagents (Amersham, Arlington 
Heights, IL). 
2.7. Kinase assay 
Cytosolic extracts containing equal amounts of proteins 
from each condition were incubated in a final volume of 
50/zl containing 50 mM fl-glycerophosphate (pH7.3), 1.5 
mM EGTA, 0.1 mM sodium orthovanadate, 1 mM dithio- 
threitol, 10/~M calmidazolium, 10 mM MgCI2, 10/~g/ml 
leupeptin, 10 /zg/ml aprotinin, 2 /.Lg/ml pepstatin A, 1 
mM benzamidine, 0.3 mM [y-32p]ATP (sp. act. 2000 
cpm/pmol) and 0.5 mg/ml myelin basic protein (MBP) 
for 20 rain at 37°C [40]. Reactions were terminated by the 
addition of 50/zl of cold 20% TCA. 50/~1 of the mix was 
then spotted on P-81 phosphocellulose filter. The filter was 
washed four times (5 min each) in 0.5% phosphoric acid 
and once with absolute thanol. The filter was dried and 
the radioactivity was measured as described above. 
Densitometric analysis of the autoradiograms exposed 
in the linear range of film density was made on an LKB 
laser densitometer. All experiments were performed at 
least twice, with similar results unless otherwise indicated. 
3. Results and discussion 
We reported earlier that hydrogen peroxide induces 
arachidonic acid release from prelabeled VSMC and the 
arachidonic acid mediates hydrogen peroxide-stimulated 
protooncogene expression [1,2]. The present investigation 
sought to identify the enzyme responsible for hydrogen 
peroxide-induced release of arachidonic acid in VSMC. 
Several studies have demonstrated that cPLA 2 is specific 
for substrates of membrane phospholipids with arachidonic 
acid at the sn-2 position 1111-16]. In addition, it was 
demonstrated that growth factors and hormones activate 
cPLA 2 via its phosphorylafion [18-23]. To test whether 
hydrogen peroxide-stimulated r lease of arachidonic acid 
is mediated by cPLA2, the effect of hydrogen peroxide on 
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Fig. 1. Time-course of hydrogen peroxide-induced phosphorylation f
cPLA 2. Growth-arrested VSMC were labeled with [32P]orthophosphate 
and exposed to 200 /zM hydrogen peroxide for the indicated times. 
Aliquots of cell lysates containing equal amounts of TCA-precipitable 
cpm were incubated with polyclonal cPLA 2 antiserum. The immuno- 
precipitates were separated on a 0.1% SDS, 10% polyacrylamide gel. 
32 P-labeled cPLA 2 was identified by its apparent molecular mass (= 97 
kDa) on the autoradiogram and is similar to that reported in Rat-2 cells 
[18]. Results shown are representative of one experiment performed 
twice. 
cPLA  2 phosphorylation was determined using polyclonal 
cPLA 2 antibodies. Hydrogen peroxide stimulated a rapid 
and time-dependent i crease in the phosphorylation of
cPLA 2 (Fig. 1). Increases (0.8-fold) in the phosphorylation 
of cPLA 2 by hydrogen peroxide were evident at 10 min 
and reached a maximum of 3-fold by 30 min. To find 
whether the time-course of hydrogen peroxide-induced 
phosphorylation of cPLA 2 correlates temporally with 
arachidonic acid release, [3H]arachidonie acid-prelabeled, 
growth-arrested VSMC were exposed to 200 /~M hydro- 
gen peroxide for varying times and [3H]arachidonic acid 
release in the medium was measured. Hydrogen peroxide 
caused time-dependent i creases in arachidonic acid re- 
lease (Fig. 2). Together, these results suggest that cPLA 2 
accounts, at least in part, for arachidonic acid release 
induced by hydrogen peroxide in VSMC. 
Previous tudies from other laboratories as well as ours 
demonstrated that phosphorylation f cPLA 2 by growth 
factors and hormones occurs on serine residue(s) [18,21- 
23]. To determine the amino acid residue of cPLA 2 phos- 
phorylated by hydrogen peroxide, phosphoamino acid 
analysis of cPLA 2 was performed. Serine was found to be 
the only amino acid residue of cPLA 2 phosphorylated by
hydrogen peroxide (Fig. 3). This result is consistent with 
earlier findings on serine phosphorylation of cPLA 2 in 
response to growth factors and hormones [18,21-23], and 
suggests that hydrogen peroxide may share the kinase 
cascade of activities with the above agonists to stimulate 
this enzyme. 
Numerous tudies indicated that PKC plays an impor- 
tant role in agonist-induced release of arachidonic acid 
[12,19,41,42]. To gain insight into the kinase cascade 
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Fig. 2. Time-course of hydrogen peroxide-induced release of 
[3H]arachidonic a id. VSMC were labeled with [3H]arachidonic a id and 
growth-arrested before exposure to vehicle (©) or 200 /~M hydrogen 
peroxide (0 )  for the indicated times. [3H]arachidonic a id released in the 
medium was separated and identified by thin layer chromatography. 
Points represent the mean + S.D. of values from two independent experi- 
ments performed in duplicate. 
leading to the activation of cPLA 2 by hydrogen peroxide, 
we examined the role of PKC, a major agonist-responsive 
serine-threonine protein kinase, in this event. PKC was 
down-regulated by exposure of VSMC to 1 /zM phorbol 
12,13-dibutyrate (PDBu) for 24 h. We and others have 
previously shown that this regimen is sufficient to deplete 
cellular PKC levels significantly (> 90%) in VSMC and 
other cell types [12,23,43]. Growth-arrested, PKC-depleted 
VSMC were labeled with [32 P]orthophosphate for 4 h and 
treated with and without 200 /xM hydrogen peroxide for 
30 min and cell lysates prepared. Cell lysates containing 
equal amounts of counts/min from control and hydrogen 
peroxide-treated VSMC were immunoprecipitated with 
po lyc lona l  cPLA  2 antibodies and the immunoprecipitants 
were analyzed by SDS-PAGE. As shown in Fig. 4, PKC 
depletion significantly (50%) reduced the hydrogen perox- 
ide-induced phosphorylation of cPLA 2. To determine 
whether PKC depletion also results in diminished release 
of arachidonic acid, [3H]arachidonic acid-prelabeled, 
growth-arrested, PKC-depleted VSMC were treated with 
Fig. 3. Phosphoamino acid analysis of cPLA 2. Phosphorylated cPLA 2 by 
hydrogen peroxide was immunoprecipitated, separated on SDS-PAGE, 
transferred to a PVDF membrane and acid hydrolyzed. Phosphoamino 
acids were separated by electrophoresis on a cellulose TLC plate. Stan- 
dards were visualized with ninhydrin and 32 P-labeled amino acids de- 
tected by autoradiography. Results shown are representative of one 
experiment performed twice. 
04 
O 
o,I 
'3- 
4"- 
, , ,  = = 
c- 0 m m 
o ~ a a 
0 "I" G_ 13_ 
~.- cPLA 2 
i i i  
iiii 
Fig. 4. PKC dependence of hydrogen peroxide-induced phosphorylation 
of cPLA:. Growth-arrested, PKC-depleted VSMC were labeled with 
[32p]orthophosphate andexposed to 200 /xM hydrogen peroxide for 30 
min. Cell lysates were treated as in Fig. 1 and cPLA 2 was separated by 
SDS-PAGE. Results shown are representative of one experiment per- 
formed twice. 
and without 200 /xM hydrogen peroxide for 30 min and 
the [3H]arachidonic acid released in the medium was 
measured. PKC depletion completely blocked the hydro- 
gen peroxide-induced release of arachidonic acid (Fig. 5). 
Similar results were obtained by use of the PKC inhibitor 
staurosporine (data not shown). These findings uggest that 
PKC plays an important role in hydrogen peroxide-induced 
phosphorylation f cPLA 2 and [3H]arachidonic acid re- 
lease. Because hydrogen peroxide-stimulated phosphoryla- 
tion of cPLA 2 temporally correlates with arachidonic acid 
release and PKC down-regulation reduces the responsive- 
ness of these events to induction by hydrogen peroxide, it 
is likely that cPLA 2 plays a role in hydrogen peroxide-in- 
duced release of arachidonic acid. The present findings are 
consistent with those of others [18,19,22] in macrophages, 
CHO cells and HL60 cells where a correlation between 
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Fig. 5. Role of PKC 
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in hydrogen peroxide-induced release of 
[3H]arachidonic acid. [3H]arachidonic acid-prelabeled, growth-arrested, 
PKC-depleted VSMC were exposed to 200 /.tM hydrogen peroxide and 
[3H]arachidonic a id released in the medium was measured as described 
in Section 2. Results represent mean + S.D. obtained from three separate 
experiments. 
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agonist - induced cPLA2 phosphory lat ion and 
[3H]arachidonic acid release has been demonstrated. The 
present findings on the role of PKC in hydrogen peroxide- 
stimulated cPLA 2 phosphorylation and [3H]arachidonic 
acid release are also in agreement with those of Lin et al. 
[18] and Xing and Mattera [19] in CHO cells and HL60 
cells, respectively, where PI(C inhibition or down-regu- 
lation blocked the agonist-induced cPLA: phosphorylation 
and [3H]arachidonic a id release. In fact, it has also been 
demonstrated that PKC is able to phosphorylate and acti- 
vate cPLA 2 in cell-free systems [20,21], although in one 
case PKC-mediated cPLA 2 phosphorylation did not result 
in a proportionate increase iin its activity [20]. It is of 
interest hat PKC depletion attenuated hydrogen peroxide- 
stimulated cPLA 2 phosphorylation byonly 50% whereas it 
completely blocked the hydrogen peroxide-induced release 
of arachidonic acid. A likely explanation for this discrep- 
ancy is that both cPLA 2 and sPLA 2 contribute to hydro- 
gen peroxide-induced release of arachidonic acid in a 
PKC-dependent manner. Indeed, Asaoka et al. [44] have 
demonstrated that PKC mediates PLA: activation in lym- 
phocytes in response to treatments with agonists. 
Mitogen-activated protein (MAP) kinase, a 
serine/threonine protein kinase, is reported to phospho- 
rylate and activate cPLA 2 in cell-free systems [20,21] as 
well as in intact CHO cells [20]. Since hydrogen peroxide 
mimicked growth factors to phosphorylate cPLa 2 on ser- 
ine residue(s), it was intriguing to examine whether MAP 
kinases play a role in hydrogen peroxide-stimulated phos- 
phorylation of cPLA 2. To test this, we studied the effect of 
hydrogen peroxide on MAP kinase activation using two 
different approaches: (i) gel mobility shift assay, and (ii) 
[32p]orthophosphate incorporation i to myelin basic pro- 
tein (MBP). The first approach is based on the fact that the 
phosphorylated and activated form of MAP kinase protein 
migrates more slowly than the non-phosphorylated inactive 
form on SDS-PAGE [45]. The second approach is a con- 
ventional method of determining MAP kinase activity 
using a specific substrate such as MBP [40]. Growth-arre- 
sted VSMC were treated with and without 200 #M hydro- 
gen peroxide for various times, cell extracts prepared and 
divided into two aliquots. One aliquot was used for West- 
ern blotting whereas the second one was used for MBP 
phosphorylation assay. As shown in Fig. 6, hydrogen 
peroxide caused a shift in the mobility of MAP kinase 
protein on SDS-PAGE and increased MBP phosphoryla- 
tion as compared to controls. Angiotensin II, which was 
previously reported to activate MAP kinases in this cell 
system [46,47], also shifted the mobility of MAP kinase 
protein on SDS-PAGE and caused substantial increases in 
the phosphorylation f MBP (Fig. 6). Since cPLA 2 has 
been reported to be a substrate for MAP kinase, and 
hydrogen peroxide increased this kinase activity, it is 
likely that hydrogen peroxide-induced activation of cPLA2,  
at least in part, is mediated by MAP kinase. 
Phosphorylation a d actiwttion of cPLA 2 by hydrogen 
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Fig. 6. Effect of hydrogen peroxide or angiotensin II on MAP kinase 
activation. Growth-arrested VSMC were exposed to vehicle, 200 /zM 
hydrogen peroxide or 100 nM angiotensin II for the indicated times and 
cell lysates prepared. Cell lysates containing equal amounts of proteins 
from each condition were immunoblotted with ERK-1 and ERK-2 anti- 
serum (A), or assayed for [32p]orthophosphate incorporation into myelin 
basic protein (B). Results hown in panel A are representative of one 
experiment (performed twice) and in panel B are mean-I-S.D, of three 
separate experiments. 
peroxide may have several implications in VSMC. It was 
reported that active oxygen (AO) species cause vasocon- 
striction [26]. Arachidonic acid and its metabolites were 
also reported to be potent vasoconstrictors [27]. Because 
cPLA 2 is specific for phospholipid substrates with arachi- 
donic acid at the sn-2 position, and hydrogen peroxide, 
one of the AO species, stimulates cPLA 2 in VSMC, it is 
likely that cPLAE-dependent generation of arachidonic 
acid and its metabolites play a role in AO species-induced 
vasoconstriction. Future studies should determine whether 
hydrogen peroxide also increases production of arachi- 
donic acid metabolites in VSMC. 
Several recent studies demonstrated that arachidonic 
acid and its metabolites play a role in growth factor-in- 
duced mitogenesis [28,29]. It was also reported that lipoxy- 
genase-cytochrome P-450 monooxygenase-dependent 
metabolites of arachidonic acid stimulate growth in various 
cell types including VSMC [30-33]. We reported previ- 
ously that hydrogen peroxide induces protooncogene ex- 
pression and DNA synthesis in VSMC [48] and that arachi- 
donic acid mediates these events [1,2]. As hydrogen perox- 
ide-induced arachidonic acid release appears to be medi- 
ated by cPLA2,  it is possible that this enzyme may medi- 
ate the hydrogen peroxide-stimulated growth events in 
VSMC. 
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